Global Guaifenesin (API) Competitive Landscape Professional Research Report 2025

Global Guaifenesin (API) Competitive Landscape Professional Research Report 2025



Research Summary

Guaifenesin is an active pharmaceutical ingredient (API) commonly used as an expectorant in over-the-counter cough and cold medications. As an expectorant, guaifenesin works by thinning and loosening mucus in the airways, making it easier for individuals to cough up and clear respiratory passages. This helps alleviate symptoms associated with respiratory conditions such as coughs, chest congestion, and bronchitis. Guaifenesin is often formulated in various cough syrups, tablets, and combination medications to provide relief from symptoms of respiratory congestion. It is considered a safe and effective medication when used as directed, but individuals should always follow recommended dosage guidelines and consult healthcare professionals if they have specific health concerns or conditions.

According to DIResearch's in-depth investigation and research, the global Guaifenesin (API) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Guaifenesin (API) include Granules, Synthokem Labs, Haizhou Pharma, Yuan Cheng Group, Stellar Chemical, Seven Star Pharma, Iwaki Seiyaku, Gennex Lab, Pan Drugs, Delta Synthetic, Smart Pharm etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Guaifenesin (API). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Guaifenesin (API) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Guaifenesin (API) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Guaifenesin (API) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Guaifenesin (API) Include:

Granules

Synthokem Labs

Haizhou Pharma

Yuan Cheng Group

Stellar Chemical

Seven Star Pharma

Iwaki Seiyaku

Gennex Lab

Pan Drugs

Delta Synthetic

Smart Pharm

Guaifenesin (API) Product Segment Include:

98%-99%

Above 99%

Guaifenesin (API) Product Application Include:

Pharmaceuticals

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Guaifenesin (API) Industry PESTEL Analysis

Chapter 3: Global Guaifenesin (API) Industry Porter’s Five Forces Analysis

Chapter 4: Global Guaifenesin (API) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Guaifenesin (API) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Guaifenesin (API) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Guaifenesin (API) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Guaifenesin (API) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Guaifenesin (API) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Guaifenesin (API) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Guaifenesin (API) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Guaifenesin (API) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Guaifenesin (API) Market Overview
1.1 Product Definition and Statistical Scope
1.2 Guaifenesin (API) Product by Type
1.2.1 98%-99%
1.2.2 Above 99%
1.3 Guaifenesin (API) Product by Application
1.3.1 Pharmaceuticals
1.3.2 Others
1.4 Global Guaifenesin (API) Market Revenue and Sales Analysis
1.4.1 Global Guaifenesin (API) Revenue Market Size Analysis (2020-2032)
1.4.2 Global Guaifenesin (API) Sales Market Size Analysis (2020-2032)
1.4.3 Global Guaifenesin (API) Market Sales Price Trend Analysis (2020-2032)
1.5 Guaifenesin (API) Industry Trends and Innovation
1.5.1 Guaifenesin (API) Industry Trends and Innovation
1.5.2 Guaifenesin (API) Market Drivers and Challenges
2 Guaifenesin (API) Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Guaifenesin (API) Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Guaifenesin (API) Market Analysis by Regions
4.1 Guaifenesin (API) Overall Market: 2024 VS 2025 VS 2032
4.2 Global Guaifenesin (API) Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Guaifenesin (API) Revenue and Market Share by Region (2020-2025)
4.2.2 Global Guaifenesin (API) Revenue and Market Share Forecast by Region (2026-2032)
4.3 Global Guaifenesin (API) Sales and Forecast Analysis (2020-2032)
4.3.1 Global Guaifenesin (API) Sales and Market Share by Region (2020-2025)
4.3.2 Global Guaifenesin (API) Sales Forecast by Region (2026-2032)
4.4 Global Guaifenesin (API) Sales Price Trend Analysis (2020-2032)
5 Global Guaifenesin (API) Market Size by Type and Application
5.1 Global Guaifenesin (API) Market Size by Type
5.1.1 Global Guaifenesin (API) Revenue and Forecast Analysis by Type (2020-2032)
5.1.2 Global Guaifenesin (API) Sales and Forecast Analysis by Type (2020-2032)
5.2 Global Guaifenesin (API) Market Size by Application
5.2.1 Global Guaifenesin (API) Revenue and Forecast Analysis by Application (2020-2032)
5.2.2 Global Guaifenesin (API) Sales and Forecast Analysis by Application (2020-2032)
6 North America
6.1 North America Guaifenesin (API) Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Guaifenesin (API) Market Size by Type
6.3.1 North America Guaifenesin (API) Sales by Type (2020-2032)
6.3.2 North America Guaifenesin (API) Revenue by Type (2020-2032)
6.4 North America Guaifenesin (API) Market Size by Application
6.4.1 North America Guaifenesin (API) Sales by Application (2020-2032)
6.4.2 North America Guaifenesin (API) Revenue by Application (2020-2032)
6.5 North America Guaifenesin (API) Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Guaifenesin (API) Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Guaifenesin (API) Market Size by Type
7.3.1 Europe Guaifenesin (API) Sales by Type (2020-2032)
7.3.2 Europe Guaifenesin (API) Revenue by Type (2020-2032)
7.4 Europe Guaifenesin (API) Market Size by Application
7.4.1 Europe Guaifenesin (API) Sales by Application (2020-2032)
7.4.2 Europe Guaifenesin (API) Revenue by Application (2020-2032)
7.5 Europe Guaifenesin (API) Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Guaifenesin (API) Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Guaifenesin (API) Market Size by Type
8.3.1 China Guaifenesin (API) Sales by Type (2020-2032)
8.3.2 China Guaifenesin (API) Revenue by Type (2020-2032)
8.4 China Guaifenesin (API) Market Size by Application
8.4.1 China Guaifenesin (API) Sales by Application (2020-2032)
8.4.2 China Guaifenesin (API) Revenue by Application (2020-2032)
9 APAC (excl. China)
9.1 APAC (excl. China) Guaifenesin (API) Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Guaifenesin (API) Market Size by Type
9.3.1 APAC (excl. China) Guaifenesin (API) Sales by Type (2020-2032)
9.3.2 APAC (excl. China) Guaifenesin (API) Revenue by Type (2020-2032)
9.4 APAC (excl. China) Guaifenesin (API) Market Size by Application
9.4.1 APAC (excl. China) Guaifenesin (API) Sales by Application (2020-2032)
9.4.2 APAC (excl. China) Guaifenesin (API) Revenue by Application (2020-2032)
9.5 APAC (excl. China) Guaifenesin (API) Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Guaifenesin (API) Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Guaifenesin (API) Market Size by Type
10.3.1 Latin America Guaifenesin (API) Sales by Type (2020-2032)
10.3.2 Latin America Guaifenesin (API) Revenue by Type (2020-2032)
10.4 Latin America Guaifenesin (API) Market Size by Application
10.4.1 Latin America Guaifenesin (API) Sales by Application (2020-2032)
10.4.2 Latin America Guaifenesin (API) Revenue by Application (2020-2032)
10.5 Latin America Guaifenesin (API) Market Size by Country
10.6 Latin America Guaifenesin (API) Market Size by Country
10.6.1 Mexico
10.6.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Guaifenesin (API) Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Guaifenesin (API) Market Size by Type
11.3.1 Middle East & Africa Guaifenesin (API) Sales by Type (2020-2032)
11.3.2 Middle East & Africa Guaifenesin (API) Revenue by Type (2020-2032)
11.4 Middle East & Africa Guaifenesin (API) Market Size by Application
11.4.1 Middle East & Africa Guaifenesin (API) Sales by Application (2020-2032)
11.4.2 Middle East & Africa Guaifenesin (API) Revenue by Application (2020-2032)
11.5 Middle East Guaifenesin (API) Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Guaifenesin (API) Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
12.1.1 Global Guaifenesin (API) Market Sales by Key Manufacturers (2021-2025)
12.1.2 Global Guaifenesin (API) Market Revenue by Key Manufacturers (2021-2025)
12.1.3 Global Guaifenesin (API) Average Sales Price by Manufacturers (2021-2025)
12.2 Guaifenesin (API) Competitive Landscape Analysis and Market Dynamic
12.2.1 Guaifenesin (API) Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Granules
13.1.1 Granules Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Granules Guaifenesin (API) Product Portfolio
13.1.3 Granules Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.2 Synthokem Labs
13.2.1 Synthokem Labs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Synthokem Labs Guaifenesin (API) Product Portfolio
13.2.3 Synthokem Labs Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.3 Haizhou Pharma
13.3.1 Haizhou Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Haizhou Pharma Guaifenesin (API) Product Portfolio
13.3.3 Haizhou Pharma Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.4 Yuan Cheng Group
13.4.1 Yuan Cheng Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Yuan Cheng Group Guaifenesin (API) Product Portfolio
13.4.3 Yuan Cheng Group Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.5 Stellar Chemical
13.5.1 Stellar Chemical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Stellar Chemical Guaifenesin (API) Product Portfolio
13.5.3 Stellar Chemical Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.6 Seven Star Pharma
13.6.1 Seven Star Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Seven Star Pharma Guaifenesin (API) Product Portfolio
13.6.3 Seven Star Pharma Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.7 Iwaki Seiyaku
13.7.1 Iwaki Seiyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Iwaki Seiyaku Guaifenesin (API) Product Portfolio
13.7.3 Iwaki Seiyaku Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.8 Gennex Lab
13.8.1 Gennex Lab Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Gennex Lab Guaifenesin (API) Product Portfolio
13.8.3 Gennex Lab Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.9 Pan Drugs
13.9.1 Pan Drugs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Pan Drugs Guaifenesin (API) Product Portfolio
13.9.3 Pan Drugs Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.10 Delta Synthetic
13.10.1 Delta Synthetic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Delta Synthetic Guaifenesin (API) Product Portfolio
13.10.3 Delta Synthetic Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.11 Smart Pharm
13.11.1 Smart Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Smart Pharm Guaifenesin (API) Product Portfolio
13.11.3 Smart Pharm Guaifenesin (API) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Guaifenesin (API) Industry Chain Analysis
14.2 Guaifenesin (API) Industry Raw Material and Suppliers Analysis
14.2.1 Guaifenesin (API) Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Guaifenesin (API) Typical Downstream Customers
14.4 Guaifenesin (API) Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings